NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000008786

Registered date:28/08/2012

WJOG6510GTR: Study of genetic biomarkers to predict efficacy in patients with wild-type KRAS metastatic colorectal cancer receiving Panitumumab + Irinotecan or Cetuximab + Irinotecan

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedAdvanced colorectal cancer
Date of first enrollment2013/05/01
Target sample size120
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeTo evaluate the correlation between the efficacy or safety and the genetic polymorphism in patients with cetuximab plus irinotecan or panitumumab plus irinotecan therapy.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaNot applicable

Related Information

Contact

public contact
Name Shinichiro Nakamura
Address Namba Plaza Bldg.3F 1-5-7,Motomachi Naniwa-ku, Osaka Japan
Telephone 06-6633-7400
E-mail datacenter@wjog.jp
Affiliation West Japan Oncology Group datacenter
scientific contact
Name Hiroya Taniguchi
Address 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681 Japan Japan
Telephone 055-989-5222
E-mail h.taniguchi@aichi-cc.jp
Affiliation Aichi Cancer Center Hospital Department of Clinical Oncology